Introduction Esophageal atresia/tracheo-esophageal fistula (EA/TEF) has an incidence of approximately 1:3,500. The incidence of malrotation is thought to be 1:200-500. We attempted to define the incidence of a combination and discuss the implications. Methods This was a retrospective review of all patients admitted to a single institution with a diagnosis of EA or EA/TEF or TEF between April 1981 and January 2013. Patients were included if the position of the duodenojejunal flexure (DJF) was determined by upper GI contrast study (UGIS), surgery or post-mortem. Results Case notes were reviewed for 235 patients. In the EA type A group, 3/28 (11 %; 95 % CI 3.7-27.2 %) had malrotation, significantly higher than the reported incidence of malrotation in the general population (p = 0.0008). All three patients in this group were symptomatic with one patient found to have a volvulus at emergency surgery. In the type C group, 6/196 (3 %, 95 % CI 1.4-6.5 %) had malrotation, significantly higher than the incidence reported for the general population (p = 0.0033) but not significantly different to that of the type A group (p = 0.0878). There were no patients with malrotation identified in any other EA/TEF type. In total, 9/235 (3.8 %; 95 % CI 2.0-7.2 %) patients with EA had malrotation, significantly higher than the 5/1,050 (0.48 %) reported for the general population (p = 0.0002).
Introduction
Esophageal atresia with or without tracheo-esophageal fistula (EA or EA/TEF) is a congenital condition with an incidence of approximately 1:3,500 live births. Various forms have been described, with the most widely used anatomic description being that of Gross [1] . The most frequent form is EA in combination with a distal tracheoesophageal fistula (Gross type C), with others including: isolated EA (type A), EA with proximal tracheo-esophageal fistula (type B), EA with both proximal tracheoesophageal fistulae (type D) and TEF with no atresia (type E; H-type). There are many described associations with the most common being the VACTERL association (Vertebral defects, Anal atresia, Cardiac defects, Tracheo-Esophageal fistula, Renal malformations, and Limb defects) which should be investigated for in any baby presenting with EA/ TEF. The syndromic forms of EA/TEF are reported to occur in approximately 50 % of patients and usually involve a cardiac anomaly [2] .
Malrotation is a congenital abnormality that manifests as abnormal bowel configuration. During the 6th week of gestation, the intestine is described to herniate into the putative umbilical cord and return into the abdomen rotating 270°anticlockwise as it does so. It then lies in the usual configuration with a wide-based mesentery fixed to the retroperitoneum. In malrotation this re-entry into the abdominal cavity is misguided resulting in a spectrum of abnormal positioning and fixation of the bowel. In its worst form, the small bowel mesentery is narrow and the midgut can rotate on its pedicle leading to volvulus with obstruction of the arterial inflow and venous outflow. This can result in loss of the entire midgut due to ischaemia and necrosis. Post-mortem studies [3] and radiological studies on the position of the caecum [4] give the overall incidence of malrotation as being 1:200-1:500. However, there is no indication of whether any, some or all of those patients were symptomatic. Most malrotations, presumably, remain asymptomatic. Although Marx [5] attempted to divide malrotation into sub-types which were at risk of volvulus or not, they are often difficult to determine clinically and radiologically. The resultant diagnostic uncertainty and potential catastrophic outcomes of death and severe short bowel syndrome if volvulus occurs often preclude expectant management of any patients with an upper gastrointestinal contrast study (UGIS) showing malrotation.
In lieu of these difficulties we attempted to define the incidence of malrotation in EA/TEF patients at a single institution. The literature defines the overall incidence of malrotation in EA/TEF as 3-5 %, [6, 7] with some studies reporting the number of patients who had a upper gastrointestinal contrast study (UGIS) and some detailing the presence or otherwise of associated symptoms. There is no literature detailing the incidence of malrotation in particular types of EA/TEF which this paper aims to address.
Methods
A retrospective review of prospectively collected data was performed of all patients admitted to our institution between April 1981 and January 2013 with a diagnosis of esophageal atresia and/or tracheo-esophageal fistula. This included patients who had their primary procedure at another hospital or who were referred to any specialty at our institution. Patients who had a diagnosis of malrotation were also reviewed and the two groups cross-referenced.
EA/TEF anatomical category according to the Gross classification, symptomatology, UGIS images and operative procedures performed were reviewed.
Numbers were compared against the best evidence available for the prevalence of malrotation.
Statistical analysis was performed using Graph Pad Prism 6 (Graph Pad, San Diego, CA, USA) and figures are median (range) unless stated. Fishers exact test was used for statistical interpretation with a p value of \0.05 taken as significant.
Results
Total number of patients identified with EA/TEF and who had confirmation of duodeno-jejunal flexure (DJF) position by UGIS, laparotomy/laparoscopy or post-mortem was 235.
Of these, 28 were Gross type A (12 %), 196 type C (83 %), 2 type D (1 %) and 9 type E (4 %).
There were three patients with type A EA/TEF who had malrotation, comprising two who had the diagnosis made on UGIS and one who underwent laparotomy for suspected jejunal atresia, but was found to have a malrotation and volvulus.
There were six patients with type C EA/TEF who had malrotation. Four were diagnosed on pre-operative UGIS as work up for a gastrostomy insertion and/or fundoplication. One was diagnosed at surgery for duodenal atresia, and the other at surgery for a pyloroplasty, who was noted to have an unfixed caecum and malrotation and so a Ladd's procedure was performed.
There were no patients in the type B, D, or E EA/TEF groups who were diagnosed with malrotation. In total, 9/235 (3.8 %) patients had malrotation. In view of the small numbers of patients with malrotation, we have calculated the 95 % confidence interval of this proportion, which is 2.0-7.2 %.
This figure is significantly higher than the 5/1,050 (0.48 %) reported in post-mortems (p = 0.0002) [3] .
In the type A group, 3/28 (11 %; 95 % CI 3.7-27.2) had malrotation, which was also significantly higher than the reported incidence (Smith; p = 0.0008). In the type C group, 6/196 (3 %, 95 % CI 1.4-6.5 %) had malrotation, significantly higher than the incidence reported by Smith (p = 0.0033), but not significantly different to the type A group (p = 0.0878).
Co-morbidities of patients with EA and malrotation are shown in Table 1 .
Discussion
EA/TEF is a well-recognised congenital abnormality with very good evidence of its prevalence and a definitive investigation and management plan. Although controversies exist in its embryological origins, the fundamental morphogenetic processes are well recognised [8] . The consequences of not treating it are profoundly deleterious to the patient.
In contrast, malrotation is a more nebulous condition. Its embryological origins are uncertain and, despite general acceptance of its anatomical development, unproven [9] .
The management of symptomatic malrotation is a Ladd's procedure, but the management of asymptomatic malrotation is unclear. Whether to perform a prophylactic Ladd's procedure continues to be a matter or great debate because of its well-established relationship to midgut volvulus, which can cause significant morbidity and mortality.
Estimates of its prevalence vary greatly and the definitive answer as to which patients with malrotation are susceptible to volvulus remains elusive.
The best estimates at prevalence come from work done a century ago in 1910 by Smith [3] who undertook postmortems in 1,050 children and discovered 5 patients with left sided and unfixed large bowel with a narrow small bowel mesentery. These clearly fit the contemporary definition of malrotation, but his study does not elaborate on the causes of death in these patients. Kantor [4] looked at contrast enema studies and determined the position of the caecum and appendix which was abnormal in 1 in 500 patients.
Marx [5] described malrotation, nonrotation and inverted rotation, but ascertained that they were all at risk of volvulus. Contemporary authors disagree alluding that the bowel in nonrotation is not at risk of volvulus and, that in any case, following the Ladd's procedure, the bowel is placed in nonrotation. However, volvulus is still possible with nonrotation and depends on the degree of fixation to the posterior abdominal wall. Millar reports such a case in a child with Beckwith-Wiedemann syndrome [10] .
Those with a fixed caecum are at low risk of volvulus, but categorising as ''low-risk'' an abnormality which can cause significant bowel loss and death is difficult. There will always be the patient who disproves the rule, but the risk to benefit ratio of performing a Ladd's procedure in an asymptomatic patient is debatable.
Mehall [11] showed that patients with asymptomatic or atypical malrotation have a higher rate of morbidity due to complications. These outcomes are mirrored by those of Papillion [12] who looked at patients with heterotaxia undergoing Ladd's procedures and found that the incidence of complications was higher in those who had asymptomatic malrotation. Malek [13] in an elegant decision tree analysis showed that the number of quality adjusted life years (QUALY's) justified a Ladd's procedure up until the age of 19.8 years in asymptomatic malrotation diagnosed outside infancy. Mehall and Schey [11, 14] independently attempted to develop risk stratification schemata based on the ligament of Trietz and the position of the caecum, but these have not been independently verified or gained wide usage. Hsiao [15] in 2011 advocated the use of laparoscopy in equivocal cases to assess the base of the mesentery and proceed to a Ladd's procedure if abnormal with good results and minimal complications.
This study raises a number of questions, not least; at what level of prevalence do we investigate for associated anomalies. Clearly we cannot hope to answer that within the remit of this paper, but relevant examples include: testing for cystic fibrosis (CF) in patients with rectal prolapse (*4 % of patients with CF present this way), investigations for VACTERL association, CHARGE association, neoplastic disease in Beckwith-Wiedemann (estimated risk for overall tumour development is 7.5 (range 4-21) %) [16] , Wilms in WAGR and Denys-Drash. In patients with these conditions, investigations for specific associated conditions are a standard of care as they can cause significant morbidity.
In Ashcraft's [17] international book on paediatric surgery it is quoted that in combination with EA/TEF, ''Of the gastrointestinal anomalies, the most frequently encountered are duodenal atresia and malrotation, and, in addition, there is an increased incidence of pyloric stenosis found.'' In Puri and Höllwarth's [18] text on paediatric surgery it reminds us that ''The most common gastrointestinal associated anomaly (with EA/TEF) is anorectal atresia (9 %), followed by duodenal atresia (5 %), malrotation (4 %), and other intestinal atresia (1 %).'' Upadhyay [6] looked at all EA/TEF patients and found that of 60 who had had a contrast study, 3 had malrotation thus giving a figure of 1 in 20 (5 %) which is comparable with our series whose overall total was 1 in 26 (3.8 %). However, they did not split their patients into specific EA groups. De Jong et al. [19] looked at non-VACTERL anomalies in EA/TEF patients and recorded a 3.3 % incidence of malrotation. Stoll et al. [20] had 3 patients from 99 with malrotation, again around a 3 % incidence. Cieri et al. [7] investigated an active surveillance registry of structural birth defects over 11 years and found an incidence of malrotation of 4.4 % in EA/TEF patients. This study also found that patients with EA and malrotation had a generally higher prevalence of other GI anomalies compared to those who had normal rotation. Within the malrotation group there was a prevalence of 40 % with anal atresia/imperforate anus, 43 % with duodenal atresia, almost 80 % with cardiac defects, 40 % with CNS anomalies excluding hydrocephalus and almost 40 % with genital defects in both the male and female groups. They suggested that these infants have a more serious developmental insult than those without malrotation. We did not specifically look for this in our study and further research in this area would be beneficial.
Many of these studies use anomaly databases to identify patients and thus there is a potential under-reporting of cases and this should be borne in mind when appraising these results. Only this paper and that of Upadhyay [6] specifically assessed the DJF to diagnose malrotation.
Our series has found a malrotation incidence of 11 % in the group with Gross type A, a previously unreported association. This high number may be in part due to the syndromic nature of patients with pure EA. It is interesting to note that malrotation is genetically associated with EA [21] , specifically with Martinez-Friaz and microgastrialimb reduction defects. TEF has been associated with malrotation in a ZIC3 abnormality of left to right patterning [21] . Malrotation has been described in combination with EA in Feingold syndrome [22] .
Malrotation is not the only anatomical abnormality to be reported as having an increased incidence in those children with EA. Pyloric stenosis has recently been shown to have a 7.5 % incidence in EA/TEF patients [23] which is 30 times higher than the 0.25 % incidence recorded in the general population [24] . This increase did not correlate with type of EA.
Other anomalies are well documented and include those in the VACTERL association along with duodenal and other small bowel atresias.
Clearly, there are limitations to our retrospective study. We excluded patients who did not have radiological, operative or anatomical assessment of the position of the DJF and given the international referral pattern to our institution, it is feasible that some patients may have gone on to have imaging and/or surgery elsewhere. However, the overall incidence of patients with malrotation in our study is comparable to those published elsewhere (Table 2) giving credence to the figures contained within this paper.
We conclude that there is a high incidence of malrotation in patients with pure esophageal atresia. We recommend identification of the DJF position at initial gastrostomy placement where feasible or a low threshold for an upper GI contrast study in these patients via the gastrostomy, orally or via naso-gastric tube following esophageal anastomosis. There should also be a low threshold for UGIS in all EA/TEF patients. 
